Literature DB >> 8972457

Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids.

A Tokumura1, M Toujima, Y Yoshioka, K Fukuzawa.   

Abstract

Oxidative modification of low density lipoprotein (LDL) is known to be a key event for induction of atherosclerosis. However, there has been little progress in structural elucidation of oxidized lipids, especially oxidatively fragmented phospholipids retaining a glycerol backbone. In this study, we found that LDL derived from egg yolk has no platelet-activating factor (PAF) acetylhydrolase activity, and that prolonged incubation of egg yolk LDL with Cu2+ resulted in the formation of various PAF-like lipids: 1-acyl type phosphatidylcholines with an sn-2-short-chain dicarboxylate or monocarboxylate group. Only a very small amount of the PAF-like lipid having an sn-2-short-chain monocarboxylate group was detected by gas chromatography-mass spectrometry in Cu(2+)-oxidized LDL from human plasma with high PAF-acetylhydrolase activity, which has been reported to hydrolyze PAF-like lipids to lysophosphatidyl-cholines. Preincubation of plasma LDL with diisopropyl fluorophosphate dose-dependently inhibited PAF-acetylhydrolase activity, resulting in accumulation of the PAF-like lipids when the LDL was oxidized with Cu2+. As well as PAF and lysophosphatidylcholines, several PAF-like lipids were found to inhibit [3H]thymidine incorporation into cultured vascular smooth muscle cells derived from rat aorta. The possible formation of PAF-like lipids by lipid peroxidation in LDL is discussed as well as its possible significance for induction of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8972457     DOI: 10.1007/bf02587909

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  34 in total

1.  Oxidatively fragmented phosphatidylcholines activate human neutrophils through the receptor for platelet-activating factor.

Authors:  P L Smiley; K E Stremler; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

2.  The platelet-activating factor acetylhydrolase from human plasma prevents oxidative modification of low-density lipoprotein.

Authors:  D M Stafforini; G A Zimmerman; T M McIntyre; S M Prescott
Journal:  Trans Assoc Am Physicians       Date:  1992

Review 3.  Practical methods for plasma lipoprotein analysis.

Authors:  F T Hatch
Journal:  Adv Lipid Res       Date:  1968

Review 4.  Perspectives in platelet-activating factor research.

Authors:  P Braquet; L Touqui; T Y Shen; B B Vargaftig
Journal:  Pharmacol Rev       Date:  1987-06       Impact factor: 25.468

5.  Identification of sn-2-omega-hydroxycarboxylate-containing phospholipids in a lipid extract from bovine brain.

Authors:  A Tokumura; T Tanaka; T Yotsumoto; H Tsukatani
Journal:  Biochem Biophys Res Commun       Date:  1991-05-31       Impact factor: 3.575

6.  Vertebrate class distribution of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine acetylhydrolase in serum.

Authors:  M C Cabot; L A Faulkner; R J Lackey; F Snyder
Journal:  Comp Biochem Physiol B       Date:  1984

7.  Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.

Authors:  U P Steinbrecher; P H Pritchard
Journal:  J Lipid Res       Date:  1989-03       Impact factor: 5.922

8.  Novel phospholipids with aliphatic dicarboxylic acid residues in a lipid extract from bovine brain.

Authors:  A Tokumura; T Asai; K Takauchi; K Kamiyasu; T Ogawa; H Tsukatani
Journal:  Biochem Biophys Res Commun       Date:  1988-09-15       Impact factor: 3.575

9.  Lysophosphatidylcholine causes Ca2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells.

Authors:  Y Chen; S Morimoto; S Kitano; E Koh; K Fukuo; B Jiang; S Chen; O Yasuda; A Hirotani; T Ogihara
Journal:  Atherosclerosis       Date:  1995-01-06       Impact factor: 5.162

10.  Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein.

Authors:  A D Watson; M Navab; S Y Hama; A Sevanian; S M Prescott; D M Stafforini; T M McIntyre; B N Du; A M Fogelman; J A Berliner
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  13 in total

1.  Myeloperoxidase formation of PAF receptor ligands induces PAF receptor-dependent kidney injury during ethanol consumption.

Authors:  Calivarathan Latchoumycandane; Laura E Nagy; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2015-05-21       Impact factor: 7.376

2.  Involvement of phospholipids in apolipoprotein B modification during low density lipoprotein oxidation.

Authors:  A I Karakatsani; T A Liapikos; A N Troganis; D C Tsoukatos
Journal:  Lipids       Date:  1998-12       Impact factor: 1.880

Review 3.  Critical insights into cardiovascular disease from basic research on the oxidation of phospholipids: the γ-hydroxyalkenal phospholipid hypothesis.

Authors:  Robert G Salomon; Xiaodong Gu
Journal:  Chem Res Toxicol       Date:  2011-09-30       Impact factor: 3.739

4.  Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis.

Authors:  Kasey C Vickers; Colin T Maguire; Robert Wolfert; Alan R Burns; Michael Reardon; Richard Geis; Paul Holvoet; Joel D Morrisett
Journal:  J Lipid Res       Date:  2009-04-09       Impact factor: 5.922

5.  Polyunsaturated phospholipids promote the oxidation and fragmentation of gamma-hydroxyalkenals: formation and reactions of oxidatively truncated ether phospholipids.

Authors:  Xi Chen; Wujuan Zhang; James Laird; Stanley L Hazen; Robert G Salomon
Journal:  J Lipid Res       Date:  2007-12-29       Impact factor: 5.922

6.  Cytotoxic phospholipid oxidation products. Cell death from mitochondrial damage and the intrinsic caspase cascade.

Authors:  Rui Chen; Lili Yang; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2007-06-27       Impact factor: 5.157

7.  Suppression of mitochondrial function by oxidatively truncated phospholipids is reversible, aided by bid, and suppressed by Bcl-XL.

Authors:  Rui Chen; Ariel E Feldstein; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2009-08-04       Impact factor: 5.157

8.  Lipid gymnastics: evidence of complete acyl chain reversal in oxidized phospholipids from molecular simulations.

Authors:  Himanshu Khandelia; Ole G Mouritsen
Journal:  Biophys J       Date:  2009-04-08       Impact factor: 4.033

Review 9.  Generation and biological activities of oxidized phospholipids.

Authors:  Valery N Bochkov; Olga V Oskolkova; Konstantin G Birukov; Anna-Liisa Levonen; Christoph J Binder; Johannes Stöckl
Journal:  Antioxid Redox Signal       Date:  2010-04-15       Impact factor: 8.401

10.  Toxicity of oxidized phospholipids in cultured macrophages.

Authors:  Ute Stemmer; Zsuzsanna A Dunai; Daniel Koller; Gabriel Pürstinger; Elfriede Zenzmaier; Hans P Deigner; Elma Aflaki; Dagmar Kratky; Albin Hermetter
Journal:  Lipids Health Dis       Date:  2012-09-07       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.